Efficacy, safety, and tolerability of valsartan/hydrochlorothiazide in Asian patients with essential hypertension

被引：0
|
作者：
Wen-Ter Lai
Jeong-Euy Park
Neelesh Dongre
Jackson Wang
机构：
[1] Kaohsiung Medical University Hospital,Division of Cardiology, Department of Internal Medicine
[2] Samsung Medical Center,Cardiology Division
[3] Novartis Pharma AG,Scientific Operations Department, Asia
[4] Novartis (Taiwan) Co.,Pacific, Middle East & African Countries
[5] Ltd.,Scientific Operations Department
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
Asian; combination therapy; efficacy; hypertension; tolerability; valsartan/hydrochlorothiazide single pill;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：427 / 438
页数：11
相关论文
共 50 条
  • [41] Efficacy and safety of valsartan/amlodipine single-pill combination in patients with essential hypertension (PEAK LOW)
    Kizilirmak, Pinar
    Ar, Idilhan
    Ilerigelen, Baris
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2014, 42 (02): : 339 - 348
  • [42] The efficacy and safety of Sacubitril/Valsartan on pulmonary hypertension in hemodialysis patients
    Zhao, Cong
    Guo, Yanhong
    Wang, Yulin
    Wang, Liuwei
    Yu, Lu
    Liang, Yan
    Zhai, Zihan
    Tang, Lin
    FRONTIERS IN MEDICINE, 2022, 9
  • [43] Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension
    Berman, Nathaniel
    Hostetter, Thomas
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (03) : 370 - 372
  • [44] Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension
    Rakugi, Hiromi
    Tsuchihashi, Takuya
    Shimada, Kazuyuki
    Numaguchi, Hirotaka
    Nishida, Chisato
    Yamaguchi, Hiroya
    Shirakawa, Masayoshi
    Azuma, Kyoichi
    Fujita, Kenji P.
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2015, 37 (03) : 260 - 266
  • [45] Efficacy, Safety and Tolerability of Fesoterodine in Asian Patients with Overactive Bladder
    Yamaguchi, Osamu
    Nishizawa, Osamu
    Takeda, Masayuki
    Yoshida, Masaki
    Choo, Myung-Soo
    Lee, Jeong Gu
    Lin, Alex Tong-Long
    Lin, Ho-Hsiung
    Yip, Wai-Chun Andrew
    Isowa, Hitoshi
    Hiro, Shintaro
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2011, 3 (01) : 43 - 50
  • [46] SAFETY AND TOLERABILITY OF LISINOPRIL IN ELDERLY PATIENTS WITH ESSENTIAL-HYPERTENSION
    SMITH, SG
    GOMEZ, HJ
    RUSH, JE
    OTTERBEIN, ES
    MONCLOA, F
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 181 - 181
  • [47] Efficacy, safety, and tolerability of perampanel in Asian and non-Asian patients with epilepsy
    Tsai, Jing-Jane
    Ikeda, Akio
    Hong, Seung Bong
    Likasitwattanakul, Surachai
    Dash, Amitabh
    EPILEPSIA, 2019, 60 : 37 - 46
  • [48] Comparison of the Efficacy and Safety of Single-Pill Fixed-Dose Combinations of Losartan/Hydrochlorothiazide and Valsartan/Hydrochlorothiazide in Patients with Hypertension (SALT-VAT Study)
    Shiga, Yuhei
    Miura, Shin-ichiro
    Morii, Joji
    Kuwano, Takashi
    Mitsutake, Ryoko
    Uehara, Yoshinari
    Inoue, Asao
    Saku, Keijiro
    INTERNAL MEDICINE, 2011, 50 (21) : 2477 - 2483
  • [49] A DOUBLE-BLIND COMPARISON OF THE EFFICACY AND SAFETY OF LACIDIPINE AND HYDROCHLOROTHIAZIDE IN ESSENTIAL-HYPERTENSION
    CHIARIELLO, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S35 - S37
  • [50] EFFICACY AND SAFETY OF OLMESARTAN AND OLMESARTAN PLUS HYDROCHLOROTHIAZIDE COMBINED WITH AMLODIPINE IN CHINESE PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION
    Li Hongwei
    Mei Kezhi
    Hua Qi
    Dai Qiuyan
    Peng Xiaoling
    Ding Hong
    Pi Lin
    Jin Zhimin
    Zhang Daifu
    Lv Ke
    Guo Xingui
    Xu Hui
    You Hua
    Yin Pengfei
    Yu Licheng
    Yang Ming
    Yu Xiaowei
    Naotaka, Ikegami
    Zhou Shuxian
    Gao Pingjin
    HEART, 2013, 99 : A61 - A62
12345